Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline CR for Smoking Cessation
NCT00741884Phase 2Withdrawn
- Sponsor
- Pfizer
- Start
- Aug 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of varenicline in nicotine dependence (5 arms), sponsored by Pfizer. Primary endpoint: Continuous abstinence from smoking at 7 weeks. Planned start Aug 2010; status: withdrawn.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00741884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00741884.